CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

1.061B

Vuru Grade

71.43/100

Current Price

$45.26
+0.10 (+0.22%)

Growth Price

$31.06
Overvalued by 31.38%

Stability Price

$19.39
Overvalued by 57.15%

Company Metrics

  • 21.38 P/E
  • 5.15 P/S
  • 5.73 P/B
  • 2.112 EPS
  • 40.69% Cash ROIC
  • 2.38 Cash Ratio
  • 0.00 / N/A % Dividend
  • 67,148.00 Avg. Vol.
  • 27.57M Shares
  • 1.061B Market Cap.

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8% - Tale of the ...
NASDAQ - Jul 9, 2014
China Biologic Products, Inc. ( CBPO ) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
Bullish Stocks: Royale Energy, Inc. (NASDAQ:ROYL), China Biologic Products ... - Markets Insider
China Biologic Products Receives Buy Rating from Jefferies Group (CBPO)
Mideast Time - Jul 24, 2014
China Biologic Products Inc logo China Biologic Products (NASDAQ:CBPO)'s stock had its “buy” rating restated by research analysts at Jefferies Group in a report released on Thursday.
What do China Biologic Products, Bioamber, and USEC Have in Common ...
SmallCap Network - Jul 8, 2014
Last but not least, China Biologic Products Inc. is up and impressive 7.4% on Tuesday, pushing up and off the key 20-day moving average line.
Aegis Increases China Biologic Products Price Target to $55.00 (CBPO) - Mideast Time
China Biologic Products's "Buy" Rating Reaffirmed at Jefferies Group (CBPO)
Ticker Report - Jul 25, 2014
China Biologic Products Inc logo Jefferies Group reaffirmed their buy rating on shares of China Biologic Products (NASDAQ:CBPO) in a research note issued to investors on Thursday.
China Biologic Products Stock Rating Reaffirmed by Jefferies Group (CBPO)
Intercooler - Jul 26, 2014
China Biologic Products Inc logo China Biologic Products (NASDAQ:CBPO)'s stock had its “buy” rating reaffirmed by equities research analysts at Jefferies Group in a research note issued to investors on Thursday.
Traders Alert: China Biologic Products Inc (CBPO), Shaw Communications Inc ...
Investor Wired - Jun 30, 2014
China Biologic Products Inc (NASDAQ:CBPO) jumped 10.23 percent to $42.89 on Friday after the biopharmaceutical company announced pricing of a follow-on offering of its 1.55 million common shares at a price of $38 a share.
China Biologic Products PT Raised to $55.00 (CBPO)
WKRB News - Jul 10, 2014
China Biologic Products Inc logo Investment analysts at Aegis hoisted their price target on shares of China Biologic Products (NASDAQ:CBPO) from $50.00 to $55.00 in a note issued to investors on Tuesday.
Losers to Watch: China Biologic Products Inc (NASDAQ:CBPO), Applied Genetic ...
Gaining Green - Jul 11, 2014
China Biologic Products Inc (NASDAQ:CBPO) reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.22.
Market Movers - Barrick Gold Corporation (NYSE:ABX), Vale S.A. (NYSE:VALE ...
Markets Insider - Jul 24, 2014
China Biologic Products, Inc. (NASDAQ:CBPO) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
Volatile Biotech Stocks: BIND Therapeutics (NASDAQ:BIND), China Biologic ...
Crazy Joys - Jun 28, 2014
China Biologic Products Inc (NASDAQ:CBPO) said Friday that it has priced a follow-on offering of 1.55 million shares of common stock at a public offering price of $38.00 per share.